Success Stories: Our Diligent Team Supported a China-based Postdoctoral Research Scholar Secure NIW Approval, No RFE No Obstacles
Client’s Testimonial:
“Thanks for your hard-working and support for my NIW Case. I am very glad to cooperate with wegreened.com now and in the future.”
On April 29th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Scholar in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Postdoctoral Research Scholar
Country of Origin: China
Approval Notice Date: April 29th, 2021
Processing Time: 8 months
Case Summary:
A postdoctoral research scholar, profoundly in the field of pharmacology, approached the North America Immigration Law Group to help him in filing an I-140 NIW (National Interest Waiver) petition. We evaluated his qualification and professional background and noted that he held an M.Sc. in phytochemistry and a Ph.D. in pharmacology with unique and expansive expertise that has enabled him to contribute significantly to the field of pharmacology, extending the rational expectation that he will continue to advance in his field and succeed in the United States. We were highly impressed by his credentials and agreed to commence preparing his case. Thus, we included the following information in his petition packet to make his NIW case a success:
Firstly, we elaborated his research focusing on identifying novel drug targets and developing improved nanoparticle-based drug delivery systems, which addresses some of our world’s most pressing issues, including breast, ovarian, and other types of cancer. Along with, we observed that he has an impressive record of publication, the 15 peer-reviewed scientific articles, published in some of the authoritative and influential journals in the field, amassing 153 citations from 22 countries, which determines that these publications are most cited and widely recognized in the field of pharmacology.
Besides, we observed that he is an active member of the scientific community and conducted 10 peer reviews for highly acclaimed journals. His peer review experience epitomizes his esteemed role in the field of pharmacology. Not only did he publish, gather citations or judge his fellow peers’ work but also received noble funding support from the National Institutes of Health and the Department of Defense. This institution funds projects that promote the health and national interests of the United States, therefore, serves as testimony that his work is highly valuable for cancer treatment in the U.S. Moreover, he has been entrusted with upholding the high standards of the field and his service attests to the caliber of his research practice, the broad practicality, and the intrinsic importance of his findings.
Furthermore, we incorporated four recommendation letters obtained by our client from fellow experts in the field to fortify that his work is dedicated to advancing in the pharmacology field, which are matters of critical national importance. Our client is highly skilled in this area and crucial to the United States. It is challenging, if not impossible, to find another researcher who can mirror his contributions to this nationally imperative research field. Experts agree that his continued support is significant to the overall success of cancer treatment in the field, and one of them stated:
“Given his numerous successes in the field of pharmacology, [client’s] future research is certain to be equally remarkable and influential. This is just one of the many reasons why I believe that he must be allowed to remain in the United States, where he has the necessary resources to continue working on his critically important research.”
The USCIS spent 8 months adjudicating his work. Considering our team’s vast knowledge and experience in devising the NIW petition, we were certain of the petition approval without any further RFE issuance. Fortunately, USCIS approved his NIW petition, and we would sincerely like to thank him for choosing our law firm for his I-140 application.